Find Academic Supervisors

• Mucosal Immunology
• Intestinal Microbiota
• Host-Immune System Interaction
• +3 more

Dame Fiona Powrie is a Professor of Musculoskeletal Sciences at the University of Oxford and Director of the Kennedy Institute of Rheumatology . She leads the Mucosal Immunology Research Group and serves as Director of the Oxford Centre for Microbiome Studies (OCMS) and Cluster Lead in the MRC National Mouse Genetics Network Microbiome Cluster . Roles: Director of Kennedy Institute, Professor, Research Group Leader Relevant Affiliations: Wellcome Trust Governor (2018–present), Deputy Chair (2022), Royal Society Fellow (2011) Research Interests : Fiona specializes in the interplay between the intestinal microbiota and the host immune system, focusing on how dysregulation leads to inflammatory bowel disease (IBD) . Her work has elucidated the role of regulatory T cells in maintaining gut homeostasis and identified the IL-23 pathway as critical in chronic intestinal inflammation. Current efforts aim to translate these findings into clinical therapies for IBD patients. Scientific Awards and Fellowships : Ita Askonas Award (European Federation of Immunological Societies) Louis-Jeantet Prize for Medicine (2012) Honorary Lifetime Membership (British Society of Immunology, 2021) Fellow of the Royal Society (2011), EMBO (2013), Academy of Medical Sciences (2014) International Fellow of the National Academy of Sciences (2020) Advising and Leadership : Fiona leads the Mucosal Immunology group at the Kennedy Institute, mentors researchers, and contributes to national and international scientific governance. She has been instrumental in advancing microbiome and immunology research through leadership roles at the Oxford Centre for Microbiome Studies and the MRC National Mouse Genetics Network . Labs and Teams : Fiona's research group at the Kennedy Institute of Rheumatology investigates mucosal immunity and microbiome interactions, combining experimental and clinical approaches to address inflammatory diseases.

Philipp NeumannView profile

Professor

• High-Performance Computing
• Scientific Computing
• Parallel and Distributed Systems
• +4 more

Philipp Neumann is a Professor and Chair of High-Performance Computing at Helmut Schmidt University since 2019. Previously, he held roles including Senior Researcher at the German Climate Computing Center (2016–2019), Postdoc at the University of Hamburg (2017–2019), and completed his Habilitation in Scientific Computing at TU Munich (2019). He transitioned to DESY/Universität Hamburg in May 2024. Education : PhD (Dr. rer. nat.) in Scientific Computing at TU Munich (2008–2013) Habilitation in Scientific Computing at TU Munich (2019) Studies in Technomathematics at Friedrich-Alexander University Erlangen-Nuremberg (2003–2008) Research Interests focus on high-performance computing, parallel and distributed systems, computational science, and applications in climate modeling. His work bridges computational methods with medical challenges, including surgical simulation training, wound healing mechanisms, and gastrointestinal pathology. Professional Activities include leadership roles in major conferences such as steering committee member for ISPDC (since 2021) and program committee roles in IPDPS, ICCS, and IEEE Cluster. He also managed the DFG priority program SPPEXA (2013–2016). Labs/Teams include the Chair for High-Performance Computing at Helmut Schmidt University and collaborations with the German Climate Computing Center. His current work at DESY/Universität Hamburg likely expands these computational efforts into interdisciplinary research.

• Intestinal Homeostasis
• Aging Biology
• Microbial Ecology
• +3 more

Dr. Rebecca Clark is an Associate Professor in the Department of Biosciences at Durham University. Her research focuses on understanding intestinal function in health and disease using the Drosophila model. She investigates how the intestinal epithelium balances barrier function, nutrient absorption, microbial symbiosis, and cell turnover, particularly during aging and disease states. Key research questions include mechanisms of intestinal barrier failure and the interplay between nutrition and intestinal homeostasis. Her work integrates genetic, microbiological, and physiological approaches to explore aging-related pathologies. Current projects aim to identify molecular pathways linking intestinal health to longevity. Supervised postgraduate students include Ale Acevedo Marcelin, Beñat Yanez, and Fanila Shahzad. Dr. Clark’s lab uses Drosophila as a model system due to its powerful genetic tools and evolutionary relevance. Research has implications for understanding human conditions such as inflammatory bowel disease and age-related metabolic disorders. Recent findings highlight microbiota-independent aging mechanisms and the role of tricellular junctions in stem cell regulation. No scientific awards are explicitly listed in the provided materials. Her research has been published in journals like Cell , Nature Cell Biology , and Proceedings of the National Academy of Sciences .

• Equine Internal Medicine
• Equine Digestive Diseases
• Infectious Diseases in Horses
• +6 more

Lieuwke Kranenburg is an Assistant Professor at the Faculty of Veterinary Medicine , Utrecht University , specializing in Equine Internal Medicine . She provides patient care at the University Equine Clinic and teaches Master's courses in equine digestion , infectious diseases , and skin problems . Research Focus: Equine internal medicine, digestive diseases, infectious pathogens, metabolic disorders Professional Certifications: EBVS® European Veterinary Specialist in Equine Internal Medicine International Collaboration: Trained Chinese veterinarians at Heilan Equestrian Centre Publications highlight her work on equine gastric disease management, diagnostic imaging, infectious disease epidemiology, and metabolic research. She contributes to equine clinical research through peer-reviewed journals and conference abstracts. Professional Involvement: Former board member of the Equine Medicine Group and current GGP representative for FEEVA, maintaining professional networks and advancing equine veterinary practice.

• Environmental Toxicology
• Reproductive Health
• Metabolic Disorders
• +3 more

Dr. Alison Holloway is a Professor at McMaster University's Faculty of Health Sciences, specializing in environmental toxicology and reproductive health. Her research focuses on the effects of environmental contaminants (e.g., oil sands pollutants, pesticides, endocrine disruptors) on maternal and child health, metabolic disorders, and developmental outcomes. She has conducted studies on naphthenic acids, synthetic food additives, and maternal exposure to pharmaceuticals like fluoxetine. Key research areas include: Environmental contaminants' impact on reproductive systems and placental function Metabolic disturbances caused by chemical exposures during critical developmental windows Neurobehavioral and gastrointestinal effects of prenatal drug exposure Assessment of urban air pollution on in vitro fertilization (IVF) success rates Her recent work highlights the role of the tryptophan-kynurenine pathway as a biomarker of environmental stress and the obesogenic effects of bisphenol analogs and food additives. Collaborations involve interdisciplinary teams addressing environmental health, with studies published in high-impact toxicology and public health journals. Dr. Holloway's research has informed policies on chemical safety and maternal health, emphasizing cross-species markers for organismal health and risk assessment of emerging contaminants like cannabis derivatives.

Baoyu ChenView profile

Associate Professor

• Cell Biology
• Structural Biology
• Biochemistry
• +3 more

Baoyu Chen is an Associate Professor in the Department of Internal Medicine at UT Southwestern Medical Center and a member of its Division of Digestive and Liver Diseases. He holds a bachelor's degree in chemical engineering from Hunan University (China), a master's in biochemistry and molecular biology from Tsinghua University (China), and a doctorate in chemical biology from Pennsylvania State University (USA). His research integrates biochemical, biophysical, computational, and structural approaches to investigate molecular mechanisms linking membrane signaling to cytoskeletal dynamics. Education: BSc in Chemical Engineering, Hunan University, China MS in Biochemistry & Molecular Biology, Tsinghua University, China PhD in Chemical Biology, Pennsylvania State University, USA Research Interests: Dr. Chen’s work focuses on protein assemblies regulating actin polymerization and endosomal trafficking (WAVE, WASH, CCC-Retriever, Retromer complexes) and their roles in cellular processes like migration, adhesion, immune activation, and neural development. His lab employs cryo-electron microscopy and collaborations with clinicians to uncover disease mechanisms. Recent Research Trends: His publications emphasize structural insights into WAVE complex activation, endosomal trafficking regulation, and pathogen hijacking of cytoskeletal systems. These studies span cell biology, structural biology, and synthetic biology applications. Scientific Awards: His work is supported by prestigious grants including the NIH MIRA NSF CAREER Award Professional Affiliations: Active member of American Heart Association American Society for Cell Biology Society for Neuroscience Laboratory: The Stone Chen Lab at UT Southwestern investigates membrane-to-cytoskeleton signaling and its implications in human disease. The lab collaborates with biologists and clinicians and welcomes opportunities for collaboration.

Pierre MaechlerView profile

Professor

• Mitochondrial metabolism
• Beta-cell function
• Diabetes research
• +5 more

Pierre Maechler is a Professor at the University of Geneva's Faculty of Medicine in the Department of Cell Physiology and Metabolism. His research focuses on mitochondrial metabolism in pancreatic beta cells and its critical role in diabetes pathogenesis, with particular emphasis on glutamate dehydrogenase function and regulation. His laboratory investigates the molecular mechanisms of insulin secretion and beta-cell failure in Type 2 diabetes. Maechler's research interests span mitochondrial metabolism, energy homeostasis, and the molecular pathways linking nutrient sensing to insulin secretion. His work has established crucial connections between glutamate metabolism, beta-cell function, and diabetes development. He investigates how metabolic stressors like glucotoxicity and lipotoxicity impair beta-cell function through mitochondrial dysfunction. His research has expanded to include the role of glutamate dehydrogenase in multiple organs including brain, liver, and muscle, revealing systemic metabolic implications. Analysis of Maechler's publication record shows a sustained focus on beta-cell metabolism with evolving scope. Early work established fundamental mechanisms of glutamate signaling in insulin secretion, while recent publications demonstrate expansion into multi-organ metabolic regulation. His research has identified novel biomarkers for beta-cell mass, explored therapeutic targets for diabetes, and revealed unexpected roles for glutamate dehydrogenase in diverse physiological processes from muscle regeneration to brain function. The consistent thread through his work is understanding how mitochondrial metabolism governs cellular and systemic energy homeostasis. Professor Maechler has mentored numerous PhD students and postdoctoral fellows who have gone on to publish significant work in diabetes research. His laboratory collaborates extensively with clinical researchers to translate basic findings into potential therapeutic approaches for diabetes. Funding for his work likely comes from Swiss National Science Foundation and other European research agencies, supporting investigations into metabolic diseases. Maechler leads the Mitochondria and Energy Metabolism research group at the University of Geneva. His team employs a multidisciplinary approach combining molecular biology, metabolomics, and physiology to investigate metabolic regulation in health and disease. The laboratory maintains strong connections with clinical diabetes researchers, facilitating translational applications of their findings. Current work focuses on identifying novel therapeutic targets for preserving beta-cell function in diabetes.

Ali NazmiView profile

Assistant Professor

• Nutritional Immunology
• Mucosal Immunology
• Host-Pathogen Interactions
• +3 more

Dr. Ali Nazmi is an Assistant Professor in the Department of Animal Sciences and the Food for Health Discovery Theme at The Ohio State University. He holds affiliations within the College of Food, Agricultural, and Environmental Sciences (CFAES). His research focuses on nutritional immunology, host-pathogen interactions in poultry and pigs, and the metabolic roles of intestinal immune cells. Nazmi obtained his B.Sc. in Poultry Production and M.Sc. in Poultry Breeding from Ain Shams University (Egypt), followed by a Ph.D. in Animal Biology from UC Davis (2017). He completed postdoctoral training in mucosal immunology at Vanderbilt University Medical Center before joining OSU in 2021. His recent work includes studies on intraepithelial lymphocytes in intestinal health, enteric disease resistance in poultry, and swine T cell biology. Key publications address mechanisms of necrotic enteritis in chickens, unconventional T cell subsets, and cytokine regulation in colitis models. Collaborations span avian immunology, swine immunology, and semen cryopreservation techniques. Education: B.Sc. (Ain Shams), M.Sc. (Ain Shams), Ph.D. (UC Davis) Postdoc: Vanderbilt University Medical Center (mucosal immunology) Key Research Themes: Nutritional Immunology, Mucosal Immunity, Avian/Porcine Health

Xia GaoView profile

Assistant Professor

• Nutrition
• Metabolism
• Cancer Metabolism
• +7 more

Xia Gao is an Assistant Professor in the Department of Pediatrics-Nutrition and the Department of Molecular and Cellular Biology at Baylor College of Medicine. She leads the Gao Lab, based at the USDA/ARS Children's Nutrition Research Center in Houston, Texas, where she investigates the role of nutrition and metabolism in diseases such as cancer and obesity. Her research focuses on amino acid metabolism, particularly the impact of dietary methionine and serine restriction on cancer progression and therapy efficacy. She employs in vivo mouse models and in vitro systems combined with metabolomics, molecular biology, and immunology techniques. The most recent publications from her lab reveal a strong trend in cancer metabolism, especially in prostate and liver cancers, with a focus on dietary interventions, metabolic reprogramming, and immune cell metabolism. Her work bridges nutritional science and precision oncology, aiming to develop effective dietary therapies. Dietary methionine influences therapy in mouse cancer models and alters human metabolism (Nature, 2019) HNF4α regulates sulfur amino acid metabolism and confers sensitivity to methionine restriction in liver cancer (Nature Communications, 2020) Targeting glutamine metabolism in therapy-resistant prostate cancer (Oncogene, 2022) Dr. Gao is supported by competitive grants, including a CPRIT award (RP210056) on dietary methionine restriction to enhance chemotherapy, and an NIH/NCI R00 grant on methionine metabolism in cancer. These grants underscore her role as an independent investigator with significant research funding. The Gao Lab is part of the USDA/ARS Children's Nutrition Research Center, a premier research facility equipped with advanced laboratories, a metabolic kitchen, and interdisciplinary teams focused on child and adult nutrition and disease prevention.

Michael BoutrosView profile

Professor

• Functional Genomics
• Structural Genomics
• Wnt Signaling
• +7 more

Michael Boutros is a Full Professor at Heidelberg University and Head of Division at the German Cancer Research Center (DKFZ). He currently serves as Dean of the Medical Faculty at Heidelberg University (since 2023) and Director of the Marsilius Kolleg (since 2020). He has held leadership roles including Coordinator of the Functional and Structural Genomics Program at DKFZ (2014–2023) and Acting Scientific Director (2015–2016). His academic base is within the Medical Faculty, focusing on molecular oncology and functional genomics. PhD, Witten/Herdecke University (1993–1996) Postdoctoral Research, Harvard Medical School (1999–2003) MPA, John F. Kennedy School of Government, Harvard University (1999–2001) Additional training: Cold Spring Harbor Laboratory, SUNY Stony Brook His research centers on Wnt signaling, functional genomics, and cancer pathways. He leads major research initiatives such as CRC 1324 on Wnt signaling and the ERC Synergy Grant DECODE. His work integrates high-throughput screening, CRISPR, and systems biology to dissect signaling networks in cancer and development. He has pioneered genome-wide RNAi and CRISPR screens to identify novel regulators of Wnt signaling across models. The 15 most recent articles reflect a strong focus on Wnt pathway regulation using functional genomics in both Drosophila and mammalian systems. Themes include high-throughput screening, CRISPR-based validation, cross-species conservation, and therapeutic targeting. Keywords span Cancer Biology, Systems Biology, and Signal Transduction, with subfields like RNAi, ubiquitination, stem cell regulation, and machine learning in image analysis. Michael Boutros has received numerous scientific honors: Elected member, Leopoldina National Academy of Sciences (2022) Elected member, Heidelberg Academy of Sciences (2022) EMBO Member (2013) ERC Advanced Grant (2012) Johann-Georg Zimmermann Research Award (2007) EMBO Young Investigator (2005) Member, 'Die Junge Akademie' (2003) He has been a recipient of the Emmy-Noether Program, McCloy Fellowship, Boehringer Ingelheim PhD Fellowship, Studienstiftung Fellowship, and Fulbright Fellowship. As a mentor and research leader, he has supervised numerous early-career scientists and coordinated large collaborative grants including the FP7 'CancerPathways' project. He currently serves as Speaker of the Research and Strategy Commission at Heidelberg University and Managing Director of the Health and Life Science Alliance Heidelberg Mannheim. He leads the CRC 1324 on Wnt signaling and is Coordinating PI of the ERC Synergy Grant DECODE. He is also Spokesperson of DFG Research Group 1036 and Coordinator of the former FP7 Coordinated Project 'CancerPathways'. His lab employs cutting-edge functional genomics tools to decode signaling networks in cancer and development.

• Neonatology
• Immunology
• Pediatric Gastroenterology
• +3 more

Dr. Oluwabunmi (Bunmi) Olaloye is an Assistant Professor of Pediatrics in the Division of Neonatology at Yale School of Medicine. She holds appointments in Neonatal-Perinatal Medicine and is affiliated with the Janeway Society. Her academic background includes an MD from Rutgers New Jersey Medical School, pediatrics residency at University of Texas Medical Branch, and neonatology fellowship at University of Pittsburgh Medical Center. Dr. Olaloye's research focuses on immune dysfunction underlying neonatal intestinal diseases such as necrotizing enterocolitis (NEC) and spontaneous intestinal perforation (SIP). Using cutting-edge techniques like single-cell RNA sequencing and mass cytometry, her work identifies biomarkers and therapeutic targets to improve outcomes for premature infants. Key research areas include fetal immune system maturation, placental immune interactions, and gestational age-specific inflammatory responses. Her publication record spans 12 peer-reviewed articles between 2019-2025, emphasizing translational immunology and neonatal pathophysiology. Notable contributions include defining immune cell trajectories in preterm infants and developing gating guidelines for high-dimensional cytometry data. Current projects involve constructing immune cell atlases across human lifespans and investigating nutritional interventions for intestinal disorders. Laboratory affiliations include the Laboratory for Surgery, Obstetrics & Gynecology where she explores neonatal mucosal immunity. Her work integrates clinical observations with systems immunology approaches to address critical gaps in understanding prematurity-associated gastrointestinal pathologies.

Susan JebbView profile

Professor

• Public Health Policy
• Nutritional Epidemiology
• Obesity Prevention
• +6 more

Professor Susan Jebb is a leading academic in diet and population health at the University of Oxford, holding dual roles as Professor of Diet and Population Health in the Nuffield Department of Primary Care Health Sciences and Senior Research Fellow at Jesus College. She chairs the Food Standards Agency and has held influential advisory roles including the UK Government’s Foresight Report on Obesity and Public Health England’s Obesity Review Group. Her research focuses on dietary interventions for obesity prevention, behavioral change strategies in primary care, and translating scientific evidence into public health policy. Education: BSc (University of Surrey, 1986) and PhD (University of Cambridge, 1990). Early career included roles at the MRC Dunn Nutrition Unit and MRC Human Nutrition Research before moving to Oxford in 2013. Research Interests: Behavioral interventions for weight management, policy impacts on dietary behavior, and obesity-related chronic diseases. Her group conducts randomized controlled trials to improve healthcare practices and public health strategies. Notable contributions include developing school food standards and shaping hospital food policies. Awards: Awarded OBE (2008) for services to public health. Teaching and Advising: Co-leads the nutrition module in the MSc in Global Health Sciences. Supervises DPhil students in primary care and population health. Leads large-scale trials such as the NHS Diabetes Remission Programme. Public Engagement: Active in media (e.g., BBC documentaries) and collaborates with public panels to co-design research studies.

Katherine Elizabeth ChettaView profile

Assistant Professor

• Neonatology
• Preterm Infant Nutrition
• Necrotizing Enterocolitis
• +3 more

Katherine Elizabeth Chetta, M.D., serves as an Assistant Professor of Pediatrics in the College of Medicine at the Medical University of South Carolina (MUSC), practicing neonatology at Shawn Jenkins Children's Hospital in Charleston. Her clinical focus centers on critically ill newborns in the Neonatal Intensive Care Unit (NICU), with specialized expertise in preterm infant care and nutritional management. Dr. Chetta completed her educational journey with a B.S. in Chemistry (Honors) from the University of Kansas (2005), followed by her M.D. from Baylor College of Medicine (2009) where she earned Alpha Omega Alpha (AOA) distinction and High Honors. She completed Pediatrics Residency (2013) and Neonatology Fellowship (2016) at Baylor College of Medicine and the University of Texas Health & Science Center in Houston. Her research program investigates critical aspects of neonatal nutrition, particularly the biochemical properties of human milk and its role in preventing gastrointestinal disorders. Key focus areas include necrotizing enterocolitis (NEC) pathogenesis, free fatty acid metabolism in preterm milk, maternal vitamin D impacts on infant immunity, and quality improvement initiatives for human milk utilization. Collaborations span the Digestive Disease Research Center Core and Darby Children's Research Institute at MUSC, integrating laboratory science with clinical epidemiology. Analysis of her 15 most recent publications reveals dominant research trajectories: (1) Human milk composition and storage effects on infant outcomes, (2) NEC risk stratification through clinical/laboratory markers and imaging, (3) Social determinants of growth in preterm infants, and (4) Microbiome interactions with milk components. Her work bridges basic science (in vitro cytotoxicity studies) with clinical implementation (NICU quality improvement). Scientific recognition includes: Induction into Alpha Omega Alpha (AOA) Honor Medical Society Dr. Chetta actively collaborates with multidisciplinary teams across MUSC's research infrastructure, though specific grant details aren't provided in source materials. Her mentorship extends to medical trainees within the neonatology division, focusing on translational research methodologies. Current projects emphasize standardizing NEC diagnostic protocols and optimizing human milk feeding systems for vulnerable infants. She contributes to laboratory-based investigations at the Darby Children's Research Institute, particularly studying HAMLET complexes in human milk and their effects on intestinal cell metabolism. Her clinical work directly informs ongoing quality improvement initiatives aimed at increasing mother's own milk usage rates in the NICU.

Felix SchweizerView profile

Professor

• Neurobiology
• Synaptic transmission
• Neurotransmitter release
• +5 more

Felix Schweizer is Professor of Neurobiology at the David Geffen School of Medicine, University of California, Los Angeles, and concurrently serves as Interim Director of the Brain Research Institute and Chair of the Graduate Interdepartmental Program for Neuroscience, reflecting his leadership in both research and graduate training. Education Ph.D. in Biochemistry (summa cum laude), University of Basel, 1989 Research Interests Schweizer’s laboratory focuses on the molecular mechanisms of synaptic transmission and neuronal communication. Using electrophysiology, optical imaging, and quantitative proteomics, his group investigates how protein ubiquitination dynamically regulates neurotransmitter release and neuronal excitability. Recent projects explore microbial metabolite sensing by vagal afferents, the synaptic impact of environmental toxicants linked to Parkinson’s disease, and how gravitational load alters vestibular synaptic architecture. Collaborations with Drs. James Wohlschlegel (multiplexed SILAC proteomics), David Krantz (pesticide neurotoxicology), and Larry Hoffman (vestibular biology in altered gravity) extend the lab’s reach from molecular mechanisms to systems-level neuroscience. Scientific Awards No specific awards are listed in the provided text. Advising & Grants As Chair of the Graduate Interdepartmental Program for Neuroscience, Schweizer oversees interdisciplinary Ph.D. training across UCLA. The laboratory continuously hosts post-doctoral fellows and graduate students, and recent funding supports work on ubiquitin-mediated synaptic modulation, pesticide-induced neurodegeneration, and spaceflight-induced synaptic plasticity in the vestibular system. Labs & Teams The Schweizer laboratory, located in the Center for Health Sciences at UCLA, integrates electrophysiology, advanced imaging (serial EM and EM tomography), and biochemical approaches to dissect synaptic function across rodent, Drosophila, and human tissue models.

Rong XuView profile

Professor

• Artificial Intelligence
• Natural Language Processing
• Machine Learning
• +18 more

Rong Xu is a Professor of Biomedical Informatics at Case Western Reserve University School of Medicine, where she also serves as Director of the Center for AI in Drug Discovery. She is a member of the Cancer Genomics and Epigenomics Program at the Case Comprehensive Cancer Center. Dr. Xu's research focuses on developing innovative computational approaches including artificial intelligence, natural language processing, data mining, machine learning, and knowledge representation to advance biomedical discovery. Her work spans both computer science and biomedical science domains. Her computer science research interests include Artificial Intelligence, Natural Language Processing, Machine Learning, Deep Learning, Systems Biology, Data Mining, Graph Theory, and Ontology. Her biomedical science interests encompass Drug Discovery, Drug Repositioning, Disease Gene Discovery, Gene-Environment Interactions, Human Gut Microbiome, Drug Target Discovery, Drug Toxicity Prediction, Cancer Drug Toxicity, Drug Addiction, and Neuroscience Informatics. Dr. Xu's recent publications demonstrate a strong focus on applying AI and computational methods to drug discovery, particularly for neurological conditions, diabetes-related complications, and substance use disorders. Her work prominently examines the effects of GLP-1 receptor agonists like semaglutide on various health outcomes, including Alzheimer's disease, opioid use disorder, and cancer. Fellow of American College of Medical Informatics (FACMI) 2020 American College of Medical Informatics Research Scholar 2016 American Cancer Society New Investigator Award 2015 American Medical Informatics Association AACR INNOVATOR Award 2015 Landon Foundation Director's Innovator Award 2014 National Institutes of Health Siebel Scholar 2004 Dr. Xu directs the Center for AI in Drug Discovery and has received significant grant funding for her research, including a $1.4 million grant from NIDA for developing AI technologies to identify potential medications for cocaine use disorder. Her work bridges computational science with clinical applications, focusing on translating AI discoveries into practical healthcare solutions.